Heart diagnostic system
Ukrainian pre-revenue start-up is looking for €746 ths investment to organize production and sale of systems for the diagnosis of heart.
Ukrainian pre-revenue start-up is looking for €746 ths investment to organize production and sale of systems for the diagnosis of heart.
Diagnosis of heart through changes in the magnetic field, caused by the activity of the heart during the cardiac cycle. Technology allows to detect the slightest deviation of the heart function and to provide the patient with a higher diagnostic accuracy in comparison to conventional methods of diagnosis.
Advantages:
- New technology of quick screening and as a result COGS in several times lower than by competitors.
- More than 1,000 cases in the database (it increases the accuracy of diagnosis).
- Identification changes in the magnetic field of heart through SQUID.
- Special design of the bed for patient’s convenient placing.
- Full-featured software package.
- Qualitative and quantitative results.
- No need for EM shielding (it allows to saves at least €200 k).
Current status:
Previous version of the system, which has been already tested by leading cardiac clinics of the world, including the Pompidou in France and Cambridge in England.
Received letters of recommendation from leading cardiac surgeons from different countries regarding the use of our diagnostic method.
Required Investments: €746 ths
CardioScan Market (2015): € 350 M
The expected market share of the initiator (2020): € 350 M
Pay-back period: 1,71 years
Expected Fair Value of the Company in 2020: €4 230 ths
